10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

MNKD (MannKind Corp) Stock Analysis
Buy, Hold or Sell?

Let's analyze MannKind Corp together

I guess you are interested in MannKind Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – MannKind Corp’s Financial Insights
  • 📈 Technical Analysis (TA) – MannKind Corp’s Price Targets

I'm going to help you getting a better view of MannKind Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about MannKind Corp

I send you an email if I find something interesting about MannKind Corp.

1. Quick Overview

1.1. Quick analysis of MannKind Corp (30 sec.)










1.2. What can you expect buying and holding a share of MannKind Corp? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
7.5%

What is your share worth?

Current worth
$-0.18
Expected worth in 1 year
$0.34
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$0.53
Return On Investment
13.9%

For what price can you sell your share?

Current Price per Share
$3.77
Expected price per share
$3.21 - $4.05
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of MannKind Corp (5 min.)




Live pricePrice per Share (EOD)
$3.77
Intrinsic Value Per Share
$-1.52 - $2.67
Total Value Per Share
$-1.70 - $2.49

2.2. Growth of MannKind Corp (5 min.)




Is MannKind Corp growing?

Current yearPrevious yearGrowGrow %
How rich?-$58.6m-$247.1m$103.8m72.5%

How much money is MannKind Corp making?

Current yearPrevious yearGrowGrow %
Making money$7.5m$2.1m$5.4m71.8%
Net Profit Margin10.0%2.7%--

How much money comes from the company's main activities?

2.3. Financial Health of MannKind Corp (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#847 / 872

Most Revenue
#111 / 872

Most Profit
#89 / 872

Most Efficient
#120 / 872
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of MannKind Corp?

Welcome investor! MannKind Corp's management wants to use your money to grow the business. In return you get a share of MannKind Corp.

First you should know what it really means to hold a share of MannKind Corp. And how you can make/lose money.

Speculation

The Price per Share of MannKind Corp is $3.77. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of MannKind Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in MannKind Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.18. Based on the TTM, the Book Value Change Per Share is $0.13 per quarter. Based on the YOY, the Book Value Change Per Share is $0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of MannKind Corp.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.041.1%0.020.6%0.010.2%-0.01-0.2%-0.03-0.8%-0.05-1.5%
Usd Book Value Change Per Share0.082.0%0.133.5%0.030.9%0.051.3%0.020.6%0.000.1%
Usd Dividend Per Share0.000.0%0.000.0%0.010.2%0.000.1%0.000.0%0.000.1%
Usd Total Gains Per Share0.082.0%0.133.5%0.041.1%0.051.3%0.020.7%0.010.2%
Usd Price Per Share5.03-5.74-4.09-4.63-4.21-2.99-
Price to Earnings Ratio30.67--14.77-92.14-19.10-3.12--1.38-
Price-to-Total Gains Ratio65.62-12.65-162.11-28.24--40.81--17.23-
Price to Book Ratio-27.54--17.12--5.23--9.11--7.74--5.36-
Price-to-Total Gains Ratio65.62-12.65-162.11-28.24--40.81--17.23-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.77
Number of shares265
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.130.02
Usd Total Gains Per Share0.130.02
Gains per Quarter (265 shares)34.826.59
Gains per Year (265 shares)139.2626.37
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1013912922516
2027926835042
3041840757568
4055754669994
506966858124120
608368249149146
7097596311174172
801114110212199198
901253124114224224
1001393138015249250

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%6.06.00.050.0%6.014.00.030.0%8.032.00.020.0%8.077.02.09.2%
Book Value Change Per Share3.01.00.075.0%7.05.00.058.3%10.010.00.050.0%18.022.00.045.0%31.056.00.035.6%
Dividend per Share0.00.04.00.0%2.00.010.016.7%2.00.018.010.0%3.00.037.07.5%3.00.084.03.4%
Total Gains per Share3.01.00.075.0%8.04.00.066.7%11.09.00.055.0%20.020.00.050.0%33.054.00.037.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of MannKind Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0770.131-42%0.033+132%0.048+58%0.023+227%0.003+2145%
Book Value Per Share---0.183-0.469+157%-0.788+332%-0.691+278%-0.666+265%-0.695+281%
Current Ratio--2.3613.564-34%3.034-22%3.294-28%3.019-22%1.795+32%
Debt To Asset Ratio--1.1431.326-14%1.653-31%1.608-29%1.805-37%2.659-57%
Debt To Equity Ratio----0%-0%-0%-0%-0%
Dividend Per Share----0%0.007-100%0.002-100%0.001-100%0.005-100%
Enterprise Value--1326893910.0001414913946.620-6%861293556.100+54%1045190815.893+27%953213602.624+39%602384198.736+120%
Eps--0.0410.024+69%0.006+546%-0.009+123%-0.031+176%-0.055+234%
Ev To Ebitda Ratio--12.33220.037-38%23.181-47%4.110+200%-12.846+204%-8.283+167%
Ev To Sales Ratio--4.2344.759-11%3.848+10%5.241-19%7.974-47%10.034-58%
Free Cash Flow Per Share---0.0210.018-215%0.001-1585%-0.013-37%-0.027+31%-0.043+104%
Free Cash Flow To Equity Per Share---0.017-0.091+448%0.103-116%-0.010-42%0.028-160%0.006-392%
Gross Profit Margin--1.0002.143-53%-2.527+353%0.419+139%0.753+33%0.885+13%
Intrinsic Value_10Y_max--2.672----------
Intrinsic Value_10Y_min---1.518----------
Intrinsic Value_1Y_max---0.007----------
Intrinsic Value_1Y_min---0.168----------
Intrinsic Value_3Y_max--0.189----------
Intrinsic Value_3Y_min---0.494----------
Intrinsic Value_5Y_max--0.637----------
Intrinsic Value_5Y_min---0.806----------
Market Cap1145827379.840-41%1614111910.0001766667446.620-9%1285553556.100+26%1429489482.560+13%1291254102.624+25%915494473.736+76%
Net Profit Margin--0.1680.100+67%0.027+513%-0.222+232%-0.641+481%-1.931+1250%
Operating Margin--0.3090.250+24%0.157+97%-0.014+105%-0.404+231%-1.765+670%
Operating Ratio--0.7150.742-4%0.872-18%1.042-31%1.346-47%2.503-71%
Pb Ratio-20.638+25%-27.536-17.116-38%-5.230-81%-9.108-67%-7.740-72%-5.355-81%
Pe Ratio22.986-33%30.668-14.766+148%92.143-67%19.096+61%3.125+881%-1.376+104%
Price Per Share3.770-33%5.0305.743-12%4.093+23%4.634+9%4.207+20%2.991+68%
Price To Free Cash Flow Ratio-45.094+25%-60.165136.885-144%-7.628-87%33.473-280%10.614-667%2.246-2778%
Price To Total Gains Ratio49.184-33%65.62212.647+419%162.112-60%28.239+132%-40.810+162%-17.233+126%
Quick Ratio--2.9734.754-37%3.118-5%4.074-27%3.787-21%2.162+38%
Return On Assets--0.0320.018+80%0.003+842%-0.018+156%-0.053+266%-0.147+558%
Return On Equity----0%-0%-0%-0%-0%
Total Gains Per Share--0.0770.131-42%0.040+92%0.051+51%0.025+208%0.008+814%
Usd Book Value---58618000.000-143285000.000+144%-247101000.000+322%-212684250.000+263%-204101700.000+248%-212202075.000+262%
Usd Book Value Change Per Share--0.0770.131-42%0.033+132%0.048+58%0.023+227%0.003+2145%
Usd Book Value Per Share---0.183-0.469+157%-0.788+332%-0.691+278%-0.666+265%-0.695+281%
Usd Dividend Per Share----0%0.007-100%0.002-100%0.001-100%0.005-100%
Usd Enterprise Value--1326893910.0001414913946.620-6%861293556.100+54%1045190815.893+27%953213602.624+39%602384198.736+120%
Usd Eps--0.0410.024+69%0.006+546%-0.009+123%-0.031+176%-0.055+234%
Usd Free Cash Flow---6707000.0005428500.000-224%737500.000-1009%-3954583.333-41%-8273850.000+23%-12908125.000+92%
Usd Free Cash Flow Per Share---0.0210.018-215%0.001-1585%-0.013-37%-0.027+31%-0.043+104%
Usd Free Cash Flow To Equity Per Share---0.017-0.091+448%0.103-116%-0.010-42%0.028-160%0.006-392%
Usd Market Cap1145827379.840-41%1614111910.0001766667446.620-9%1285553556.100+26%1429489482.560+13%1291254102.624+25%915494473.736+76%
Usd Price Per Share3.770-33%5.0305.743-12%4.093+23%4.634+9%4.207+20%2.991+68%
Usd Profit--13158000.0007529000.000+75%2121750.000+520%-4115000.000+131%-10467050.000+180%-17175025.000+231%
Usd Revenue--78354000.00074398750.000+5%56149750.000+40%54216500.000+45%39347050.000+99%27014400.000+190%
Usd Total Gains Per Share--0.0770.131-42%0.040+92%0.051+51%0.025+208%0.008+814%
 EOD+2 -6MRQTTM+18 -18YOY+26 -123Y+26 -125Y+29 -910Y+31 -7

3.3 Fundamental Score

Let's check the fundamental score of MannKind Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1522.986
Price to Book Ratio (EOD)Between0-1-20.638
Net Profit Margin (MRQ)Greater than00.168
Operating Margin (MRQ)Greater than00.309
Quick Ratio (MRQ)Greater than12.973
Current Ratio (MRQ)Greater than12.361
Debt to Asset Ratio (MRQ)Less than11.143
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.032
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of MannKind Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.095
Ma 20Greater thanMa 503.747
Ma 50Greater thanMa 1004.171
Ma 100Greater thanMa 2004.602
OpenGreater thanClose3.750
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About MannKind Corp

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States. It offers Afrezza Inhalation Powder, an inhaled insulin used to improve glycemic control in adults with diabetes; the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults; and Tyvaso DPI for the treatment of pulmonary arterial hypertension and pulmonary hypertension. The company's product pipeline includes MNKD-101, a nebulized formulation of clofazimine, which is in Phase 3 study, for the treatment of severe chronic and recurrent pulmonary infections, including nontuberculous mycobacterial lung disease; MNKD-201, a dry-powder formulation of nintedanib, which is in phase 1 clinical study, for the treatment of idiopathic pulmonary fibrosis (IPF); MNKD-301, which is in preclinical stage, for cystic fibrosis; and Pediatric Afrezza, which is in phase 3 clinical trial for the treatment of diabetes mellitus. It has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. Further, the company has supply and distribution agreement with Biomm S.A. for the commercialization of Afrezza in Brazil; license and distribution agreement with Cipla Ltd. for the marketing and distribution of Afrezza in India; and co-promotion agreement with Amphastar for marketing of Baqsimi (glucagon) nasal powder. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut.

Fundamental data was last updated by Penke on 2025-07-11 09:50:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit MannKind Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare MannKind Corp to the Biotechnology industry mean.
  • A Net Profit Margin of 16.8% means that $0.17 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of MannKind Corp:

  • The MRQ is 16.8%. The company is making a huge profit. +2
  • The TTM is 10.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ16.8%TTM10.0%+6.8%
TTM10.0%YOY2.7%+7.3%
TTM10.0%5Y-64.1%+74.1%
5Y-64.1%10Y-193.1%+129.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ16.8%-93.6%+110.4%
TTM10.0%-140.9%+150.9%
YOY2.7%-197.6%+200.3%
3Y-22.2%-248.5%+226.3%
5Y-64.1%-343.4%+279.3%
10Y-193.1%-496.2%+303.1%
4.3.1.2. Return on Assets

Shows how efficient MannKind Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare MannKind Corp to the Biotechnology industry mean.
  • 3.2% Return on Assets means that MannKind Corp generated $0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of MannKind Corp:

  • The MRQ is 3.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.2%TTM1.8%+1.4%
TTM1.8%YOY0.3%+1.4%
TTM1.8%5Y-5.3%+7.1%
5Y-5.3%10Y-14.7%+9.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2%-11.6%+14.8%
TTM1.8%-11.6%+13.4%
YOY0.3%-11.4%+11.7%
3Y-1.8%-11.8%+10.0%
5Y-5.3%-12.0%+6.7%
10Y-14.7%-13.7%-1.0%
4.3.1.3. Return on Equity

Shows how efficient MannKind Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare MannKind Corp to the Biotechnology industry mean.
  • 0.0% Return on Equity means MannKind Corp generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of MannKind Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.5%+13.5%
TTM--14.9%+14.9%
YOY--14.6%+14.6%
3Y--16.8%+16.8%
5Y--17.5%+17.5%
10Y--19.9%+19.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of MannKind Corp.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient MannKind Corp is operating .

  • Measures how much profit MannKind Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare MannKind Corp to the Biotechnology industry mean.
  • An Operating Margin of 30.9% means the company generated $0.31  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of MannKind Corp:

  • The MRQ is 30.9%. The company is operating very efficient. +2
  • The TTM is 25.0%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ30.9%TTM25.0%+5.9%
TTM25.0%YOY15.7%+9.3%
TTM25.0%5Y-40.4%+65.5%
5Y-40.4%10Y-176.5%+136.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ30.9%-232.5%+263.4%
TTM25.0%-250.5%+275.5%
YOY15.7%-209.2%+224.9%
3Y-1.4%-234.1%+232.7%
5Y-40.4%-346.1%+305.7%
10Y-176.5%-477.5%+301.0%
4.3.2.2. Operating Ratio

Measures how efficient MannKind Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.72 means that the operating costs are $0.72 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of MannKind Corp:

  • The MRQ is 0.715. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.742. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.715TTM0.742-0.026
TTM0.742YOY0.872-0.130
TTM0.7425Y1.346-0.604
5Y1.34610Y2.503-1.158
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7152.111-1.396
TTM0.7422.694-1.952
YOY0.8723.096-2.224
3Y1.0423.652-2.610
5Y1.3464.745-3.399
10Y2.5036.614-4.111
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of MannKind Corp.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if MannKind Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.36 means the company has $2.36 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of MannKind Corp:

  • The MRQ is 2.361. The company is able to pay all its short-term debts. +1
  • The TTM is 3.564. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.361TTM3.564-1.203
TTM3.564YOY3.034+0.530
TTM3.5645Y3.019+0.545
5Y3.01910Y1.795+1.224
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3613.661-1.300
TTM3.5643.846-0.282
YOY3.0344.140-1.106
3Y3.2944.688-1.394
5Y3.0195.746-2.727
10Y1.7956.147-4.352
4.4.3.2. Quick Ratio

Measures if MannKind Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare MannKind Corp to the Biotechnology industry mean.
  • A Quick Ratio of 2.97 means the company can pay off $2.97 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of MannKind Corp:

  • The MRQ is 2.973. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.754. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.973TTM4.754-1.781
TTM4.754YOY3.118+1.635
TTM4.7545Y3.787+0.967
5Y3.78710Y2.162+1.625
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9732.848+0.125
TTM4.7543.169+1.585
YOY3.1183.786-0.668
3Y4.0744.311-0.237
5Y3.7875.703-1.916
10Y2.1626.368-4.206
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of MannKind Corp.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of MannKind Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare MannKind Corp to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.14 means that MannKind Corp assets are financed with 114.3% credit (debt) and the remaining percentage (100% - 114.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of MannKind Corp:

  • The MRQ is 1.143. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.326. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.143TTM1.326-0.183
TTM1.326YOY1.653-0.327
TTM1.3265Y1.805-0.479
5Y1.80510Y2.659-0.854
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1430.329+0.814
TTM1.3260.349+0.977
YOY1.6530.331+1.322
3Y1.6080.340+1.268
5Y1.8050.349+1.456
10Y2.6590.379+2.280
4.5.4.2. Debt to Equity Ratio

Measures if MannKind Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare MannKind Corp to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of MannKind Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.379-0.379
TTM-0.437-0.437
YOY-0.414-0.414
3Y-0.450-0.450
5Y-0.464-0.464
10Y-0.515-0.515
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings MannKind Corp generates.

  • Above 15 is considered overpriced but always compare MannKind Corp to the Biotechnology industry mean.
  • A PE ratio of 30.67 means the investor is paying $30.67 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of MannKind Corp:

  • The EOD is 22.986. Based on the earnings, the company is fair priced.
  • The MRQ is 30.668. Based on the earnings, the company is overpriced. -1
  • The TTM is -14.766. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD22.986MRQ30.668-7.682
MRQ30.668TTM-14.766+45.434
TTM-14.766YOY92.143-106.909
TTM-14.7665Y3.125-17.891
5Y3.12510Y-1.376+4.501
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD22.986-2.356+25.342
MRQ30.668-2.077+32.745
TTM-14.766-2.574-12.192
YOY92.143-3.760+95.903
3Y19.096-3.773+22.869
5Y3.125-6.193+9.318
10Y-1.376-6.876+5.500
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of MannKind Corp:

  • The EOD is -45.094. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -60.165. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 136.885. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-45.094MRQ-60.165+15.071
MRQ-60.165TTM136.885-197.050
TTM136.885YOY-7.628+144.513
TTM136.8855Y10.614+126.271
5Y10.61410Y2.246+8.368
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-45.094-3.246-41.848
MRQ-60.165-2.705-57.460
TTM136.885-3.704+140.589
YOY-7.628-4.402-3.226
3Y33.473-5.070+38.543
5Y10.614-8.477+19.091
10Y2.246-9.305+11.551
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of MannKind Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -27.54 means the investor is paying $-27.54 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of MannKind Corp:

  • The EOD is -20.638. Based on the equity, the company is expensive. -2
  • The MRQ is -27.536. Based on the equity, the company is expensive. -2
  • The TTM is -17.116. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-20.638MRQ-27.536+6.898
MRQ-27.536TTM-17.116-10.420
TTM-17.116YOY-5.230-11.886
TTM-17.1165Y-7.740-9.376
5Y-7.74010Y-5.355-2.385
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-20.6382.038-22.676
MRQ-27.5361.843-29.379
TTM-17.1162.125-19.241
YOY-5.2302.442-7.672
3Y-9.1082.492-11.600
5Y-7.7403.652-11.392
10Y-5.3554.311-9.666
4.6.2. Total Gains per Share

2.4. Latest News of MannKind Corp

Does MannKind Corp still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from MannKind Corp to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-07-01
20:01
MannKind Corp stock hits 52-week low at $3.63Read
2025-06-24
21:52
Leerink Partners Slashes MannKind Corporation’s (MNKD) Price Target to $7, Keeps a Buy RatingRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of MannKind Corp.

4.8.1. Institutions holding MannKind Corp

Institutions are holding 58.64% of the shares of MannKind Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31BlackRock Inc8.05670.0026244869394933812.0563
2025-03-31Vanguard Group Inc5.69930.00161732217912636227.8688
2025-03-31State Street Corp3.11580.0029469977-477798-4.8031
2025-03-31venBio Select Advisor LLC2.87890.687875000000
2025-03-31Nitorum Capital, L.P.2.56175.50257785702-961614-10.9932
2025-03-31Geode Capital Management, LLC2.23280.002767861054118316.4608
2025-03-31UBS Group AG2.15850.00616560268326005998.7834
2025-03-31Millennium Management LLC1.91570.01565822590237519868.8984
2025-03-31FMR Inc1.40190.00144260962-215898-4.8225
2025-03-31Bank of America Corp1.28390.0016390222453791115.9887
2025-03-31D. E. Shaw & Co LP1.26270.01723837634-431429-10.1059
2025-03-31Two Sigma Advisers, LLC1.22910.0423373562764300020.7914
2025-03-31Dimensional Fund Advisors, Inc.1.15990.0044352535556713619.1715
2025-03-31Nuveen, LLC1.11270.0052338195633819560
2025-03-31Two Sigma Investments LLC1.10510.036133586201844565.8112
2025-03-31Qube Research & Technologies1.06610.018932402961696034109.8281
2025-03-31TSP Capital Management Group/LLC0.91514.6033278135026160010.382
2025-03-31Arrowstreet Capital Limited Partnership0.89380.01112716429-2171180-44.4221
2025-03-31Northern Trust Corp0.88830.0022699799-77985-2.8075
2025-03-31Parkman Healthcare Partners LLC0.82051.48782493836-632891-20.2413
Total 41.758512.4514126917848+10107389+8.0%

4.9.2. Funds holding MannKind Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-05-31Vanguard Total Stock Mkt Idx Inv3.05410.00219282300100130.108
2025-05-31iShares Russell 2000 ETF2.21330.0453672683400
2025-05-31Vanguard Institutional Extnd Mkt Idx Tr1.43080.01654348607307980.7133
2025-04-30Fidelity Select Biotechnology1.31880.51794008401-237800-5.6003
2025-05-31SPDR® S&P Biotech ETF0.99940.26873037396179620.5949
2025-03-31Fidelity Small Cap Index0.88280.05582683118220850.8299
2025-05-31iShares Russell 2000 Growth ETF0.58810.0672178742100
2025-05-31iShares Biotechnology ETF0.57310.1448174176700
2025-05-31State St Russell Sm/Mid Cp® Indx SL Cl I0.51170.0157155511641000.2643
2025-04-30Fidelity Extended Market Index0.5110.02171553101273151.7902
2025-04-30Nuveen Quant Small Cap Equity R60.49580.24671506960-37480-2.4268
2025-05-31Vanguard Russell 2000 ETF0.44730.04451359374120840.8969
2025-05-31Schwab US Small-Cap ETF™0.42880.03261303252-3515-0.269
2025-04-30CREF Stock R30.37850.0049115035500
2025-05-31Invesco Biotechnology & Genome ETF0.37372.1296113593000
2025-03-31Oberweis Micro-Cap Growth0.31860.819496840000
2025-03-31Oberweis Micro-Cap0.31860.820296840000
2025-05-31State St Russell Sm Cap® Indx SL Cl I0.31620.0461961052227002.4191
2025-03-31Federated Hermes MDT Small Cap Core IS0.29990.3601911379-402426-30.6306
2025-03-31Federated Hermes MDT SCC Institutional0.29990.3599911379-402426-30.6306
Total 15.76046.019747900542-936590-2.0%

5.3. Insider Transactions

Insiders are holding 1.856% of the shares of MannKind Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-06-10Steven B BinderSELL640854
2025-05-20David ThomsonSELL23454.41
2025-05-20Steven B BinderSELL120784.4
2025-05-13David ThomsonSELL321794.68
2025-05-13Steven B BinderSELL801444.69
2024-11-22Steven B BinderSELL675366.89
2024-11-15Steven B BinderSELL675396.76
2024-11-06Stuart A TrossSELL550007.34
2024-09-03Stuart A TrossSELL250006.26
2024-08-30Stuart A TrossSELL800006.33
2024-08-29Michael CastagnaSELL851066.3
2024-08-29Steven B BinderSELL50555.94
2024-07-16Steven B BinderSELL28365.93
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Net Debt  180,96360,620241,583-63,677177,906-176,5491,357-1,419-62



5.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets410,141
Total Liabilities468,759
Total Stockholder Equity-58,618
 As reported
Total Liabilities 468,759
Total Stockholder Equity+ -58,618
Total Assets = 410,141

Assets

Total Assets410,141
Total Current Assets273,737
Long-term Assets136,404
Total Current Assets
Cash And Cash Equivalents 47,312
Short-term Investments 134,229
Net Receivables 28,900
Inventory 28,892
Other Current Assets 34,404
Total Current Assets  (as reported)273,737
Total Current Assets  (calculated)273,737
+/-0
Long-term Assets
Property Plant Equipment 83,781
Goodwill 1,931
Long Term Investments 16,681
Intangible Assets 5,217
Long-term Assets Other 28,794
Long-term Assets  (as reported)136,404
Long-term Assets  (calculated)136,404
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities115,937
Long-term Liabilities352,822
Total Stockholder Equity-58,618
Total Current Liabilities
Short-term Debt 36,109
Short Long Term Debt 36,109
Accounts payable 5,041
Other Current Liabilities 63,030
Total Current Liabilities  (as reported)115,937
Total Current Liabilities  (calculated)140,289
+/- 24,352
Long-term Liabilities
Capital Lease Obligations 11,141
Long-term Liabilities Other 294,321
Long-term Liabilities  (as reported)352,822
Long-term Liabilities  (calculated)305,462
+/- 47,360
Total Stockholder Equity
Common Stock3,039
Retained Earnings -3,188,661
Accumulated Other Comprehensive Income 1,174
Other Stockholders Equity 3,125,830
Total Stockholder Equity (as reported)-58,618
Total Stockholder Equity (calculated)-58,618
+/-0
Other
Capital Stock3,039
Cash and Short Term Investments 181,541
Common Stock Shares Outstanding 320,897
Current Deferred Revenue11,757
Liabilities and Stockholders Equity 410,141
Net Debt -62
Net Invested Capital -22,509
Net Working Capital 157,800
Property Plant and Equipment Gross 192,456
Short Long Term Debt Total 47,250



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-03-312002-12-31
> Total Assets 
104,773
0
125,876
128,766
110,778
181,797
163,483
141,757
114,817
260,024
228,371
191,991
144,579
149,702
539,737
482,567
418,237
364,136
543,443
465,402
399,248
331,632
282,459
275,711
267,126
288,655
247,397
243,255
239,557
305,149
277,256
254,752
228,358
224,014
199,553
251,420
240,393
210,331
251,314
215,196
212,429
287,608
258,646
224,553
236,306
386,818
394,439
360,022
352,551
278,014
126,412
93,272
139,434
96,131
107,063
85,185
79,374
56,483
84,575
61,877
62,155
45,356
107,705
100,961
81,795
95,140
93,725
80,212
102,781
95,681
108,608
319,382
252,791
238,207
321,161
308,318
285,797
293,837
295,282
298,137
313,422
320,328
475,198
480,879
443,836
464,200
393,843
410,141
410,141393,843464,200443,836480,879475,198320,328313,422298,137295,282293,837285,797308,318321,161238,207252,791319,382108,60895,681102,78180,21293,72595,14081,795100,961107,70545,35662,15561,87784,57556,48379,37485,185107,06396,131139,43493,272126,412278,014352,551360,022394,439386,818236,306224,553258,646287,608212,429215,196251,314210,331240,393251,420199,553224,014228,358254,752277,256305,149239,557243,255247,397288,655267,126275,711282,459331,632399,248465,402543,443364,136418,237482,567539,737149,702144,579191,991228,371260,024114,817141,757163,483181,797110,778128,766125,8760104,773
   > Total Current Assets 
0
0
0
61,222
43,913
112,417
95,881
72,159
45,448
187,106
149,872
109,540
58,851
62,713
449,547
383,209
298,610
219,220
378,712
277,083
187,707
102,942
53,975
35,136
38,500
63,314
37,666
34,757
33,223
102,028
73,954
50,614
26,860
27,024
5,821
59,709
50,346
23,197
66,810
32,285
32,162
99,329
76,275
39,399
44,910
195,895
201,153
158,290
145,827
71,236
76,654
44,143
90,764
48,604
77,488
56,094
50,931
28,629
57,216
35,028
35,799
19,525
81,854
69,692
49,834
61,743
60,757
49,348
72,583
66,346
79,476
288,342
179,903
159,206
219,744
184,265
193,476
218,381
234,896
223,299
230,233
225,575
373,393
383,102
325,940
327,664
268,306
273,737
273,737268,306327,664325,940383,102373,393225,575230,233223,299234,896218,381193,476184,265219,744159,206179,903288,34279,47666,34672,58349,34860,75761,74349,83469,69281,85419,52535,79935,02857,21628,62950,93156,09477,48848,60490,76444,14376,65471,236145,827158,290201,153195,89544,91039,39976,27599,32932,16232,28566,81023,19750,34659,7095,82127,02426,86050,61473,954102,02833,22334,75737,66663,31438,50035,13653,975102,942187,707277,083378,712219,220298,610383,209449,54762,71358,851109,540149,872187,10645,44872,15995,881112,41743,91361,222000
       Cash And Cash Equivalents 
19,917
0
54,120
56,111
37,373
103,871
78,987
22,089
19,552
69,238
56,037
45,889
27,056
43,086
319,555
262,753
216,429
152,298
368,285
269,079
180,454
31,582
27,648
27,114
31,328
53,918
30,019
29,052
28,358
97,928
66,061
46,912
24,770
22,786
2,681
56,355
31,639
1,765
61,840
28,005
28,529
93,803
70,790
35,759
41,214
172,465
120,841
120,844
107,187
32,928
59,074
27,653
63,733
35,530
22,895
47,978
43,384
20,092
43,946
26,706
26,178
10,446
71,157
34,530
7,968
30,173
29,906
38,868
63,222
52,398
67,005
247,833
62,522
51,740
124,184
67,243
35,507
54,308
69,767
85,869
86,184
83,016
238,480
193,272
96,643
62,373
46,339
47,312
47,31246,33962,37396,643193,272238,48083,01686,18485,86969,76754,30835,50767,243124,18451,74062,522247,83367,00552,39863,22238,86829,90630,1737,96834,53071,15710,44626,17826,70643,94620,09243,38447,97822,89535,53063,73327,65359,07432,928107,187120,844120,841172,46541,21435,75970,79093,80328,52928,00561,8401,76531,63956,3552,68122,78624,77046,91266,06197,92828,35829,05230,01953,91831,32827,11427,64831,582180,454269,079368,285152,298216,429262,753319,55543,08627,05645,88956,03769,23819,55222,08978,987103,87137,37356,11154,120019,917
       Short-term Investments 
11,135
0
1,825
3,194
3,887
5,000
11,546
44,958
22,884
113,166
89,597
56,700
23,800
7,007
116,924
102,824
67,599
51,875
0
0
0
63,651
18,844
3,115
2,639
2,649
2,475
2,488
2,414
117
4,370
549
497
513
515
350
350
350
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
350
0
0
0
4,809
527
527
527
0
24,764
24,909
19,885
19,978
0
0
0
0
28,962
99,970
87,312
79,932
95,203
118,649
110,738
101,079
80,273
58,163
58,000
56,619
107,457
151,118
189,215
150,917
134,229
134,229150,917189,215151,118107,45756,61958,00058,16380,273101,079110,738118,64995,20379,93287,31299,97028,962000019,97819,88524,90924,76405275275274,80900035000000000000000003503503505155134975494,3701172,4142,4882,4752,6492,6393,11518,84463,65100051,87567,599102,824116,9247,00723,80056,70089,597113,16622,88444,95811,5465,0003,8873,1941,825011,135
       Net Receivables 
0
0
0
0
0
1,500
1,500
1,500
537
1,233
1,194
1,044
1,043
918
2,418
3,918
3,918
3,171
831
1,875
2,250
2,625
1,500
1,675
1,850
700
1,500
1,153
1,352
674
674
674
885
765
473
0
0
350
450
450
450
298
298
380
0
803
50,436
4,282
4,748
1,679
23
144
22,742
3,137
30,859
438
1,312
1,804
2,789
1,550
2,848
2,752
4,017
3,759
4,974
4,093
3,513
5,032
3,366
4,135
4,218
3,573
6,305
9,445
4,994
9,823
15,030
23,493
16,801
19,714
27,789
21,822
14,901
19,912
23,346
18,184
11,804
28,900
28,90011,80418,18423,34619,91214,90121,82227,78919,71416,80123,49315,0309,8234,9949,4456,3053,5734,2184,1353,3665,0323,5134,0934,9743,7594,0172,7522,8481,5502,7891,8041,31243830,8593,13722,742144231,6794,7484,28250,4368030380298298450450450350004737658856746746741,3521,1531,5007001,8501,6751,5002,6252,2501,8758313,1713,9183,9182,4189181,0431,0441,1941,2335371,5001,5001,50000000
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,875
-2,250
-2,625
0
-1,675
-1,850
-700
0
-1,153
-1,352
0
0
0
-885
0
-473
0
0
-350
-450
0
0
-298
-298
-380
0
-803
9,670
16,789
19,816
23,402
13,539
13,539
2,866
5,124
2,331
3,698
3,172
3,129
2,657
3,891
3,676
2,785
3,597
3,720
3,963
3,692
4,155
3,231
3,823
4,881
4,973
5,050
7,482
7,482
7,152
8,044
20,573
18,273
21,772
21,998
25,290
27,117
28,545
26,442
24,753
26,663
27,886
28,892
28,89227,88626,66324,75326,44228,54527,11725,29021,99821,77218,27320,5738,0447,1527,4827,4825,0504,9734,8813,8233,2314,1553,6923,9633,7203,5972,7853,6763,8912,6573,1293,1723,6982,3315,1242,86613,53913,53923,40219,81616,7899,670-8030-380-298-29800-450-35000-4730-885000-1,352-1,1530-700-1,850-1,6750-2,625-2,250-1,8750000000000000000000
   > Long-term Assets 
0
0
0
67,544
66,865
69,380
67,602
69,598
69,369
72,918
78,499
82,451
85,728
86,989
90,190
99,358
119,627
144,916
164,731
188,319
211,541
228,690
228,484
240,575
228,626
225,341
209,731
208,498
206,334
203,121
203,302
204,138
201,498
196,990
193,732
191,711
190,047
187,134
184,504
182,911
180,267
188,279
182,371
185,154
191,396
190,923
193,286
201,732
206,724
206,778
49,758
49,129
48,670
47,527
29,575
29,091
28,443
27,854
27,359
26,849
26,356
25,831
25,851
31,269
31,961
33,397
32,968
30,864
30,198
29,335
29,132
31,040
72,888
79,001
101,417
124,053
92,321
75,456
60,386
74,838
83,189
94,753
101,805
97,777
117,896
136,536
125,537
136,404
136,404125,537136,536117,89697,777101,80594,75383,18974,83860,38675,45692,321124,053101,41779,00172,88831,04029,13229,33530,19830,86432,96833,39731,96131,26925,85125,83126,35626,84927,35927,85428,44329,09129,57547,52748,67049,12949,758206,778206,724201,732193,286190,923191,396185,154182,371188,279180,267182,911184,504187,134190,047191,711193,732196,990201,498204,138203,302203,121206,334208,498209,731225,341228,626240,575228,484228,690211,541188,319164,731144,916119,62799,35890,19086,98985,72882,45178,49972,91869,36969,59867,60269,38066,86567,544000
       Property Plant Equipment 
72,675
0
67,323
66,881
66,235
66,223
66,511
67,999
68,353
71,387
76,183
80,289
83,190
84,005
88,328
98,622
118,331
143,244
162,683
185,895
208,742
225,515
226,436
228,352
226,221
224,057
208,229
206,761
204,398
202,235
202,356
203,179
200,383
196,374
193,029
190,916
189,159
186,611
183,961
182,290
179,567
177,829
176,557
176,337
183,533
190,923
192,127
193,454
193,868
191,408
48,749
48,033
47,422
46,825
28,927
28,482
27,920
27,374
26,922
26,481
26,036
25,632
25,602
31,269
31,961
33,397
26,778
26,517
26,187
25,736
25,867
26,507
28,139
30,848
36,612
41,453
37,918
41,182
45,126
54,837
69,510
80,411
88,905
88,012
89,217
85,339
85,365
83,781
83,78185,36585,33989,21788,01288,90580,41169,51054,83745,12641,18237,91841,45336,61230,84828,13926,50725,86725,73626,18726,51726,77833,39731,96131,26925,60225,63226,03626,48126,92227,37427,92028,48228,92746,82547,42248,03348,749191,408193,868193,454192,127190,923183,533176,337176,557177,829179,567182,290183,961186,611189,159190,916193,029196,374200,383203,179202,356202,235204,398206,761208,229224,057226,221228,352226,436225,515208,742185,895162,683143,244118,33198,62288,32884,00583,19080,28976,18371,38768,35367,99966,51166,22366,23566,88167,323072,675
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,900
3,067
2,428
1,998
1,931
1,931
1,931
1,931
1,931
1,931
1,931
1,931
1,9311,9311,9311,9311,9311,9311,9311,9311,9982,4283,0672,9000000000000000000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
885
386
473
565
658
293
313
391
470
223
298
380
463
260
311
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,480
38,950
42,059
56,619
70,542
32,596
12,728
1,961
492
2,282
3,271
7,155
3,726
13,398
16,796
5,482
16,681
16,6815,48216,79613,3983,7267,1553,2712,2824921,96112,72832,59670,54256,61942,05938,9501,48000000000000000000000000031126046338029822347039131329365856547338688500000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,400
1,169
1,153
1,133
1,113
1,093
1,073
1,053
1,033
5,313
5,265
5,217
5,2175,2655,3131,0331,0531,0731,0931,1131,1331,1531,1691,4000000000000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Assets Other 
0
0
0
663
630
3,157
1,091
1,599
1,016
1,531
2,316
2,162
2,538
2,984
1,862
736
1,296
1,672
2,048
2,424
2,799
3,175
2,048
12,223
2,405
1,284
1,502
1,737
1,936
886
946
959
1,115
616
703
795
888
523
543
621
700
10,450
5,814
8,817
7,863
2,374
1,159
8,278
12,856
15,370
1,009
1,096
1,248
702
648
609
523
480
437
368
320
199
249
5,519
4,815
6,271
6,190
4,347
4,011
3,599
3,265
3,053
5,799
6,094
8,186
12,058
17,507
17,310
9,718
16,378
8,353
8,047
1,668
3,055
11,585
27,157
27,494
28,794
28,79427,49427,15711,5853,0551,6688,0478,35316,3789,71817,31017,50712,0588,1866,0945,7993,0533,2653,5994,0114,3476,1906,2714,8155,5192491993203684374805236096487021,2481,0961,00915,37012,8568,2781,1592,3747,8638,8175,81410,4507006215435238887957036161,1159599468861,9361,7371,5021,2842,40512,2232,0483,1752,7992,4242,0481,6721,2967361,8622,9842,5382,1622,3161,5311,0161,5991,0913,157630663000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,251
10,831
13,539
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000013,53910,8316,25100000000000000000000000000000000000000000000000
> Total Liabilities 
8,037
0
9,111
14,335
13,426
9,242
13,120
14,134
16,231
18,996
21,394
24,281
27,158
87,731
156,250
167,283
169,958
184,512
179,343
167,329
173,962
168,207
195,725
242,537
286,395
291,060
306,618
344,197
377,219
486,588
462,788
458,253
473,740
504,824
513,205
528,806
484,767
486,579
361,993
362,002
364,786
455,330
289,359
207,017
282,683
427,496
468,209
457,053
468,026
402,583
476,746
466,736
506,011
334,818
290,656
283,910
300,617
307,498
299,307
285,085
268,774
250,797
282,787
288,965
277,794
279,846
284,251
278,262
282,491
282,101
289,027
493,004
436,342
422,895
530,510
540,382
532,853
531,514
545,820
553,533
573,909
572,107
721,366
710,849
669,616
674,126
472,659
468,759
468,759472,659674,126669,616710,849721,366572,107573,909553,533545,820531,514532,853540,382530,510422,895436,342493,004289,027282,101282,491278,262284,251279,846277,794288,965282,787250,797268,774285,085299,307307,498300,617283,910290,656334,818506,011466,736476,746402,583468,026457,053468,209427,496282,683207,017289,359455,330364,786362,002361,993486,579484,767528,806513,205504,824473,740458,253462,788486,588377,219344,197306,618291,060286,395242,537195,725168,207173,962167,329179,343184,512169,958167,283156,25087,73127,15824,28121,39418,99616,23114,13413,1209,24213,42614,3359,11108,037
   > Total Current Liabilities 
7,830
0
8,707
8,636
8,048
9,184
13,044
14,086
16,188
18,960
21,365
24,257
27,134
87,707
44,959
55,853
58,411
72,847
67,558
55,447
61,958
56,079
53,472
40,159
38,889
28,425
28,853
26,300
22,189
25,565
18,134
24,395
21,558
17,313
25,360
34,407
55,441
51,764
144,775
264,211
266,782
217,387
127,794
44,515
119,233
72,625
403,353
380,753
342,254
267,307
268,324
249,211
289,706
105,832
92,051
93,049
85,869
91,468
87,597
80,669
74,901
59,627
75,241
77,868
76,978
64,287
65,618
68,248
67,939
106,124
73,705
73,116
60,429
50,033
48,349
53,494
59,564
59,597
67,296
81,853
96,966
96,374
104,125
99,896
80,012
72,101
81,837
115,937
115,93781,83772,10180,01299,896104,12596,37496,96681,85367,29659,59759,56453,49448,34950,03360,42973,11673,705106,12467,93968,24865,61864,28776,97877,86875,24159,62774,90180,66987,59791,46885,86993,04992,051105,832289,706249,211268,324267,307342,254380,753403,35372,625119,23344,515127,794217,387266,782264,211144,77551,76455,44134,40725,36017,31321,55824,39518,13425,56522,18926,30028,85328,42538,88940,15953,47256,07961,95855,44767,55872,84758,41155,85344,95987,70727,13424,25721,36518,96016,18814,08613,0449,1848,0488,6368,70707,830
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
50,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
114,443
234,228
234,379
187,830
102,300
25,871
37,744
72,625
172,350
172,961
137,880
74,163
74,582
75,010
75,452
70,888
71,339
71,795
57,484
57,942
52,745
43,654
38,002
14,202
11,298
11,385
8,974
2,520
5,028
5,101
5,387
45,379
4,061
4,670
4,873
18,430
6,977
10,498
9,470
9,525
10,489
24,843
31,593
20,000
31,984
32,235
13,099
0
0
36,109
36,1090013,09932,23531,98420,00031,59324,84310,4899,5259,47010,4986,97718,4304,8734,6704,06145,3795,3875,1015,0282,5208,97411,38511,29814,20238,00243,65452,74557,94257,48471,79571,33970,88875,45275,01074,58274,163137,880172,961172,35072,62537,74425,871102,300187,830234,379234,228114,44300000000000000000000000050,0000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
99,355
0
0
0
214,087
0
0
0
148,495
0
164,799
165,265
156,822
140,269
129,359
0
0
11,385
8,974
2,520
5,028
5,101
5,387
45,379
4,061
4,670
4,873
0
6,977
9,410
0
0
9,565
21,293
26,353
20,000
20,000
20,000
0
0
0
36,109
36,10900020,00020,00020,00026,35321,2939,565009,4106,97704,8734,6704,06145,3795,3875,1015,0282,5208,97411,38500129,359140,269156,822165,265164,7990148,495000214,08700099,3550000000000000000000000000000000000000000000000
       Accounts payable 
4,209
0
1,926
2,329
1,840
1,429
3,477
5,095
4,621
5,407
3,547
4,008
2,586
6,673
10,715
10,123
5,653
36,738
35,463
24,399
30,084
19,992
15,630
14,222
11,171
8,801
6,519
8,766
2,365
6,372
3,294
5,360
1,600
1,598
4,624
2,661
5,817
3,166
4,555
3,604
5,419
7,786
3,860
3,638
5,086
17,389
7,394
3,302
5,190
4,444
15,599
582
2,849
5,093
3,263
1,519
6,541
5,283
6,984
4,976
9,237
5,815
5,379
6,978
7,533
11,664
4,789
6,731
5,821
5,797
5,582
6,706
7,486
9,528
6,956
8,702
7,823
9,871
11,052
13,889
17,127
16,754
9,580
7,149
9,556
6,444
6,792
5,041
5,0416,7926,4449,5567,1499,58016,75417,12713,88911,0529,8717,8238,7026,9569,5287,4866,7065,5825,7975,8216,7314,78911,6647,5336,9785,3795,8159,2374,9766,9845,2836,5411,5193,2635,0932,84958215,5994,4445,1903,3027,39417,3895,0863,6383,8607,7865,4193,6044,5553,1665,8172,6614,6241,5981,6005,3603,2946,3722,3658,7666,5198,80111,17114,22215,63019,99230,08424,39935,46336,7385,65310,12310,7156,6732,5864,0083,5475,4074,6215,0953,4771,4291,8402,3291,92604,209
       Other Current Liabilities 
3,621
0
6,781
4,947
4,835
6,382
9,567
8,991
11,567
13,553
17,818
20,249
24,548
31,034
34,244
45,730
52,758
36,109
32,095
31,048
31,874
36,087
37,842
25,937
27,718
19,624
22,334
17,534
19,824
19,193
14,840
19,035
19,958
15,715
20,736
31,746
49,624
48,598
140,220
26,379
26,984
5,493
5,706
15,006
76,403
203,764
223,609
204,490
199,184
188,700
178,138
173,619
211,405
27,837
14,030
17,891
19,252
25,222
24,830
32,039
27,662
39,610
58,564
27,121
28,101
17,891
23,298
25,576
24,547
26,081
30,787
35,860
27,944
26,489
33,589
32,987
40,604
38,415
44,022
40,805
44,757
55,950
51,915
51,086
62,612
57,632
62,589
63,030
63,03062,58957,63262,61251,08651,91555,95044,75740,80544,02238,41540,60432,98733,58926,48927,94435,86030,78726,08124,54725,57623,29817,89128,10127,12158,56439,61027,66232,03924,83025,22219,25217,89114,03027,837211,405173,619178,138188,700199,184204,490223,609203,76476,40315,0065,7065,49326,98426,379140,22048,59849,62431,74620,73615,71519,95819,03514,84019,19319,82417,53422,33419,62427,71825,93737,84236,08731,87431,04832,09536,10952,75845,73034,24431,03424,54820,24917,81813,55311,5678,9919,5676,3824,8354,9476,78103,621
   > Long-term Liabilities 
0
0
0
5,699
5,378
58
76
48
43
36
29
24
24
24
111,291
111,430
111,547
111,665
111,785
111,882
112,004
112,128
142,253
202,378
247,506
262,635
277,765
317,897
355,030
461,023
444,654
433,858
452,182
487,511
487,845
494,399
429,326
434,815
217,218
97,791
98,004
237,943
161,565
162,502
163,450
354,871
64,856
76,300
125,772
135,276
208,422
217,525
216,305
228,986
198,605
190,861
214,748
216,030
211,710
204,416
193,873
191,170
207,546
211,097
200,816
215,559
218,633
210,014
214,552
175,977
215,322
419,888
375,913
372,862
482,161
486,888
473,289
471,917
478,524
471,680
476,943
475,733
617,241
610,953
589,604
602,025
390,822
352,822
352,822390,822602,025589,604610,953617,241475,733476,943471,680478,524471,917473,289486,888482,161372,862375,913419,888215,322175,977214,552210,014218,633215,559200,816211,097207,546191,170193,873204,416211,710216,030214,748190,861198,605228,986216,305217,525208,422135,276125,77276,30064,856354,871163,450162,502161,565237,94398,00497,791217,218434,815429,326494,399487,845487,511452,182433,858444,654461,023355,030317,897277,765262,635247,506202,378142,253112,128112,004111,882111,785111,665111,547111,430111,2912424242936434876585,3785,699000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
209,979
210,308
210,642
210,946
211,184
211,673
97,583
97,791
98,004
98,220
98,439
98,662
98,889
72,625
0
0
35,713
27,607
27,613
27,618
27,623
27,629
27,635
27,642
27,649
27,657
24,411
24,368
19,161
19,133
19,099
19,065
19,031
7,437
5,000
5,000
5,000
5,000
5,000
222,855
223,217
223,580
223,944
224,307
224,670
225,034
225,397
225,761
0
0
0
0
0
0
0
0
00000000225,761225,397225,034224,670224,307223,944223,580223,217222,8555,0005,0005,0005,0005,0007,43719,03119,06519,09919,13319,16124,36824,41127,65727,64927,64227,63527,62927,62327,61827,61327,60735,7130072,62598,88998,66298,43998,22098,00497,79197,583211,673211,184210,946210,642210,308209,97900000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
-50,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-114,443
-234,228
-234,379
-187,830
-102,300
-25,871
-37,744
-72,625
-172,350
-172,961
-137,880
-74,163
-74,582
-75,010
-75,452
-70,888
-71,339
-71,795
-57,484
-57,942
-52,745
-43,654
-38,002
-14,202
-11,298
-7,770
-5,880
226
-2,514
-2,946
-3,544
-43,856
-2,859
-3,801
-4,309
-17,632
-5,937
-9,672
-3,542
-3,859
-5,146
-19,964
-26,947
-15,711
-28,059
-28,590
-9,643
12,338
11,645
-24,968
-24,96811,64512,338-9,643-28,590-28,059-15,711-26,947-19,964-5,146-3,859-3,542-9,672-5,937-17,632-4,309-3,801-2,859-43,856-3,544-2,946-2,514226-5,880-7,770-11,298-14,202-38,002-43,654-52,745-57,942-57,484-71,795-71,339-70,888-75,452-75,010-74,582-74,163-137,880-172,961-172,350-72,625-37,744-25,871-102,300-187,830-234,379-234,228-114,443000000000000000000000000-50,0000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,251
10,831
13,539
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000013,53910,8316,25100000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
242,203
277,203
277,203
283,453
218,142
223,142
119,635
0
0
139,941
63,126
63,840
64,561
61,093
64,856
76,300
90,059
107,669
180,809
189,907
188,682
201,357
163,589
162,467
186,494
188,373
187,299
180,048
174,712
172,037
188,447
192,032
89,179
93,121
213,633
205,014
209,552
170,977
210,322
197,033
88,018
149,282
258,217
262,581
248,619
246,883
67,440
245,919
59,835
148,681
294,767
295,364
292,455
296,596
291,966
294,321
294,321291,966296,596292,455295,364294,767148,68159,835245,91967,440246,883248,619262,581258,217149,28288,018197,033210,322170,977209,552205,014213,63393,12189,179192,032188,447172,037174,712180,048187,299188,373186,494162,467163,589201,357188,682189,907180,809107,66990,05976,30064,85661,09364,56163,84063,126139,94100119,635223,142218,142283,453277,203277,203242,20300000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,381
752
605
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000006057527,381000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
96,736
0
116,765
114,431
97,352
172,555
150,363
127,623
98,586
241,028
206,977
167,710
117,421
61,971
383,487
315,284
248,279
179,624
364,100
298,073
225,286
163,425
86,734
33,174
-19,269
-2,405
-59,221
-100,942
-137,662
-181,439
-185,532
-203,501
-245,382
-280,810
-313,652
-277,386
-244,374
-276,248
-110,679
-146,806
-152,357
-167,722
-30,713
17,536
-46,377
-40,678
-73,770
-97,031
-115,475
-124,569
-350,334
-373,464
-366,577
-238,687
-183,593
-198,725
-221,243
-251,015
-214,732
-223,208
-206,619
-205,441
-175,082
-188,004
-195,999
-184,706
-190,526
-198,050
-179,710
-186,420
-180,419
-173,622
-183,551
-184,688
-209,349
-232,064
-247,056
-237,677
-250,538
-255,396
-260,487
-251,779
-246,168
-229,970
-225,780
-209,926
-78,816
-58,618
-58,618-78,816-209,926-225,780-229,970-246,168-251,779-260,487-255,396-250,538-237,677-247,056-232,064-209,349-184,688-183,551-173,622-180,419-186,420-179,710-198,050-190,526-184,706-195,999-188,004-175,082-205,441-206,619-223,208-214,732-251,015-221,243-198,725-183,593-238,687-366,577-373,464-350,334-124,569-115,475-97,031-73,770-40,678-46,37717,536-30,713-167,722-152,357-146,806-110,679-276,248-244,374-277,386-313,652-280,810-245,382-203,501-185,532-181,439-137,662-100,942-59,221-2,405-19,26933,17486,734163,425225,286298,073364,100179,624248,279315,284383,48761,971117,421167,710206,977241,02898,586127,623150,363172,55597,352114,431116,765096,736
   Common Stock
165
0
200
200
200
327
327
327
328
501
503
496
496
499
734
734
735
736
1,014
1,014
1,016
1,017
1,020
1,020
1,036
1,128
1,130
1,134
1,137
1,234
1,278
1,307
1,309
1,313
1,315
1,678
1,993
1,998
2,860
2,894
3,012
3,100
3,697
3,869
3,964
4,055
4,061
4,090
4,121
4,182
4,287
4,290
4,777
4,784
4,784
958
1,046
1,047
1,192
1,260
1,456
1,594
1,870
1,878
1,894
2,064
2,118
2,131
2,289
2,309
2,421
2,491
2,496
2,502
2,515
2,524
2,573
2,632
2,638
2,643
2,682
2,695
2,700
2,703
2,740
2,753
3,029
3,039
3,0393,0292,7532,7402,7032,7002,6952,6822,6432,6382,6322,5732,5242,5152,5022,4962,4912,4212,3092,2892,1312,1182,0641,8941,8781,8701,5941,4561,2601,1921,0471,0469584,7844,7844,7774,2904,2874,1824,1214,0904,0614,0553,9643,8693,6973,1003,0122,8942,8601,9981,9931,6781,3151,3131,3091,3071,2781,2341,1371,1341,1301,1281,0361,0201,0201,0171,0161,0141,0147367357347344994964965035013283273273272002002000165
   Retained Earnings Total Equity00000000-3,227,264-3,217,469-3,199,522-3,185,090-3,156,067-3,130,069-3,102,008-3,097,582-3,062,059-3,049,143-3,022,732-3,011,477-3,001,225-2,991,903-2,977,640-2,967,270-2,954,883-2,940,000-2,930,249-2,906,085-2,883,410-2,854,898-2,822,114-2,789,228-2,753,889-2,737,565-2,791,540-2,918,060-2,888,102-2,863,229-2,586,214-2,554,353-2,525,447-2,494,784-2,458,343-2,421,824-2,348,458-2,296,402-2,242,819-2,192,001-2,145,877-2,104,912-2,053,131-2,010,298-1,973,719-1,935,546-1,899,149-1,860,74700000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-1,591
-1,463
-1,490
-19,368
7
8
8
-25,381
-27,371
-29,466
-31,200
-33,146
-35,177
-36,620
-38,590
-40,726
-42,370
-43,994
-47,387
295
354
-119
-107
-281
-272
-1
-78,103
74
86
38
45
44
-3
-9
-8
-6
-8
-8
-9
-4
-4
-4
-11
-14
-21
-20
-19
-20
-19
-21
-21
-24
-24
-21
-20
-18
-15
-18
-18
-19
-19
-19
-20
-19
-95,768
-96,168
-96,623
0
0
0
0
0
-1,076
-1,206
-1,206
0
0
443
443
0
0
0
588
1,109
1,174
1,1741,10958800044344300-1,206-1,206-1,07600000-96,623-96,168-95,768-19-20-19-19-19-18-18-15-18-20-21-24-24-21-21-19-20-19-20-21-14-11-4-4-4-9-8-8-6-8-9-34445388674-78,103-1-272-281-107-119354295-47,387-43,994-42,370-40,726-38,590-36,620-35,177-33,146-31,200-29,466-27,371-25,381887-19,368-1,490-1,463-1,591000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,614,018
1,616,981
1,620,535
1,694,658
1,763,939
1,774,893
1,991,379
1,996,185
2,036,640
2,072,006
2,261,996
2,362,129
2,371,487
2,413,621
2,416,967
2,424,347
2,434,777
2,457,482
2,508,633
2,510,367
2,546,727
2,548,090
2,549,212
2,554,230
2,566,960
2,570,072
2,638,992
2,658,957
2,698,028
2,723,232
2,763,067
2,765,020
2,769,396
2,790,890
2,799,278
2,801,044
2,829,478
2,834,003
2,866,303
2,885,946
2,911,535
2,914,818
2,918,205
2,922,555
2,936,667
2,960,419
2,964,293
2,969,225
0
0
0
0
0
0
0
0
000000002,969,2252,964,2932,960,4192,936,6672,922,5552,918,2052,914,8182,911,5352,885,9462,866,3032,834,0032,829,4782,801,0442,799,2782,790,8902,769,3962,765,0202,763,0672,723,2322,698,0282,658,9572,638,9922,570,0722,566,9602,554,2302,549,2122,548,0902,546,7272,510,3672,508,6332,457,4822,434,7772,424,3472,416,9672,413,6212,371,4872,362,1292,261,9962,072,0062,036,6401,996,1851,991,3791,774,8931,763,9391,694,6581,620,5351,616,9811,614,01800000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
434,202
435,240
595,531
592,999
592,414
590,530
764,529
763,775
768,074
772,536
778,053
1,170,602
1,175,540
1,180,523
1,184,914
1,444,125
1,449,519
1,456,556
1,463,191
1,469,497
1,475,290
1,478,908
1,541,223
1,544,112
1,547,077
1,552,335
1,631,866
1,587,932
1,611,373
1,614,018
1,616,981
1,620,579
1,694,658
1,763,940
1,774,893
1,991,379
1,996,185
2,036,640
2,072,006
2,261,996
2,362,129
2,371,487
2,413,621
2,416,967
2,424,347
2,434,777
2,457,482
2,508,633
2,510,367
2,546,727
2,548,090
2,549,212
2,554,230
2,566,960
2,570,072
2,638,992
2,658,957
2,698,028
2,723,232
2,763,067
2,765,020
2,769,396
2,790,890
2,799,278
2,801,044
2,829,478
2,834,003
2,866,303
2,885,946
2,911,535
2,914,818
2,918,205
2,922,555
2,936,667
2,960,419
2,964,293
2,969,225
2,968,917
2,975,891
2,980,539
2,986,104
2,992,271
2,995,974
3,118,865
3,125,830
3,125,8303,118,8652,995,9742,992,2712,986,1042,980,5392,975,8912,968,9172,969,2252,964,2932,960,4192,936,6672,922,5552,918,2052,914,8182,911,5352,885,9462,866,3032,834,0032,829,4782,801,0442,799,2782,790,8902,769,3962,765,0202,763,0672,723,2322,698,0282,658,9572,638,9922,570,0722,566,9602,554,2302,549,2122,548,0902,546,7272,510,3672,508,6332,457,4822,434,7772,424,3472,416,9672,413,6212,371,4872,362,1292,261,9962,072,0062,036,6401,996,1851,991,3791,774,8931,763,9401,694,6581,620,5791,616,9811,614,0181,611,3731,587,9321,631,8661,552,3351,547,0771,544,1121,541,2231,478,9081,475,2901,469,4971,463,1911,456,5561,449,5191,444,1251,184,9141,180,5231,175,5401,170,602778,053772,536768,074763,775764,529590,530592,414592,999595,531435,240434,202000



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue285,504
Cost of Revenue-76,602
Gross Profit208,902208,902
 
Operating Income (+$)
Gross Profit208,902
Operating Expense-140,222
Operating Income72,58768,680
 
Operating Expense (+$)
Research Development45,893
Selling General Administrative94,329
Selling And Marketing Expenses0
Operating Expense140,222140,222
 
Net Interest Income (+$)
Interest Income12,615
Interest Expense-37,981
Other Finance Cost-0
Net Interest Income-25,366
 
Pretax Income (+$)
Operating Income72,587
Net Interest Income-25,366
Other Non-Operating Income Expenses0
Income Before Tax (EBT)30,518114,656
EBIT - interestExpense = 30,518
30,518
65,569
Interest Expense37,981
Earnings Before Interest and Taxes (EBIT)68,49968,499
Earnings Before Interest and Taxes (EBITDA)77,467
 
After tax Income (+$)
Income Before Tax30,518
Tax Provision-2,930
Net Income From Continuing Ops27,58827,588
Net Income27,588
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses199,395
Total Other Income/Expenses Net-42,06925,366
 

Technical Analysis of MannKind Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of MannKind Corp. The general trend of MannKind Corp is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine MannKind Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. MannKind Corp Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of MannKind Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.97 < 4 < 4.05.

The bearish price targets are: 3.57 > 3.47 > 3.21.

Know someone who trades $MNKD? Share this with them.👇

MannKind Corp Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of MannKind Corp. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

MannKind Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of MannKind Corp. The current macd is -0.1239403.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the MannKind Corp price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for MannKind Corp. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the MannKind Corp price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
MannKind Corp Daily Moving Average Convergence/Divergence (MACD) ChartMannKind Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of MannKind Corp. The current adx is 24.10.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell MannKind Corp shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
MannKind Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of MannKind Corp. The current sar is 3.528752.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
MannKind Corp Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of MannKind Corp. The current rsi is 45.09. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
MannKind Corp Daily Relative Strength Index (RSI) ChartMannKind Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of MannKind Corp. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the MannKind Corp price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
MannKind Corp Daily Stochastic Oscillator ChartMannKind Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of MannKind Corp. The current cci is 26.25.

MannKind Corp Daily Commodity Channel Index (CCI) ChartMannKind Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of MannKind Corp. The current cmo is -1.05598534.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
MannKind Corp Daily Chande Momentum Oscillator (CMO) ChartMannKind Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of MannKind Corp. The current willr is -46.93877551.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that MannKind Corp is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
MannKind Corp Daily Williams %R ChartMannKind Corp Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of MannKind Corp.

MannKind Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of MannKind Corp. The current atr is 0.15061269.

MannKind Corp Daily Average True Range (ATR) ChartMannKind Corp Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of MannKind Corp. The current obv is -22,720,471.

MannKind Corp Daily On-Balance Volume (OBV) ChartMannKind Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of MannKind Corp. The current mfi is 27.44.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
MannKind Corp Daily Money Flow Index (MFI) ChartMannKind Corp Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for MannKind Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-03-11ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-21BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

MannKind Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of MannKind Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.095
Ma 20Greater thanMa 503.747
Ma 50Greater thanMa 1004.171
Ma 100Greater thanMa 2004.602
OpenGreater thanClose3.750
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of MannKind Corp with someone you think should read this too:
  • Are you bullish or bearish on MannKind Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about MannKind Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about MannKind Corp

I send you an email if I find something interesting about MannKind Corp.


Comments

How you think about this?

Leave a comment

Stay informed about MannKind Corp.

Receive notifications about MannKind Corp in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.